In addition, all detected laminins were down-regulated in tumour samples compared to matched non-tumour samples, from 1.8-fold for laminin α2 chain (LAMA2) to 18.6-fold for laminin α3 chain (LAMA3) (Supplementary Figure 2; Supplementary Data 3). The gene discussed is LAMB2; the disease is neoplasm.